Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(11%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
6
67%
Ph phase_4
2
22%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed3
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (11.1%)
Phase 42 (22.2%)
N/A6 (66.7%)

Trials by Status

unknown444%
withdrawn111%
recruiting111%
completed333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9